Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


NEURONASCENT, INC.

NEURONASCENT, INC. Patent applications
Patent application numberTitlePublished
20100298318METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS AND INHIBITING NEURONAL DEGENERATION USING ISOTHIAZOLOPYRIMIDINONES - The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, traumatic nerve injury, and depression. This invention is useful for resear products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.11-25-2010
20090305403Isolation and Differentiation of Adult Hippocampal Arctic Squirrel Neural Stem Cells - Neuronal stem cell lines derived from the Arctic Ground Squirrel, methods related to culturing and maintaining a neuronal stem cell line derived from the Arctic Ground Squirrel and a culture media required to maintain and differentiate a neuronal stem cell line derived from the Arctic Ground Squirrel is disclosed. Antibodies specific for antigens expressed on a neuronal stem cell line derived from the Arctic Ground Squirrel, and products and methods related to the use of neuronal stem cell lines derived from the Arctic Ground Squirrel are also included.12-10-2009
20080234253Methods and Compositons for Stimulating Neurogenesis and Inhibiting Neuronal Degeneration - The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, and depression. This invention could also be used for research products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.09-25-2008